Pulse Biosciences (PLSE) Cost of Revenue (2021 - 2025)

Historic Cost of Revenue for Pulse Biosciences (PLSE) over the last 3 years, with Q3 2025 value amounting to $279000.0.

  • Pulse Biosciences' Cost of Revenue changed N/A to $279000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $279000.0, marking a year-over-year change of. This contributed to the annual value of $11.9 million for FY2022, which is 50691.06% up from last year.
  • According to the latest figures from Q3 2025, Pulse Biosciences' Cost of Revenue is $279000.0.
  • Pulse Biosciences' 5-year Cost of Revenue high stood at $8.4 million for Q3 2022, and its period low was $279000.0 during Q3 2025.
  • For the 3-year period, Pulse Biosciences' Cost of Revenue averaged around $2.0 million, with its median value being $1.2 million (2021).
  • Data for Pulse Biosciences' Cost of Revenue shows a peak YoY increase of 105543.33% (in 2022) and a maximum YoY decrease of 402.9% (in 2022) over the last 5 years.
  • Pulse Biosciences' Cost of Revenue (Quarter) stood at $1.2 million in 2021, then grew by 4.03% to $1.3 million in 2022, then tumbled by 78.39% to $279000.0 in 2025.
  • Its last three reported values are $279000.0 in Q3 2025, $1.3 million for Q4 2022, and $8.4 million during Q3 2022.